Innovation beyond borders

But challenges bring with them opportunity. At Eureka, we’ve reinforced our commitment to supporting you, entrepreneurs, whose great innovations make a positive societal impact and strengthen our economies.

Why Eurostars is an essential component of Horizon Europe.

Insights

1. Horizon Europe emphasises the need to reinforce support to SMEs for the research and development of emerging and breakthrough innovations. There is a need for policies directly targeting SMEs and that aim to close the innovation gap in the European Union.
2. The Innovative SMEs Partnership delivers a unique 1:3 leverage cash effect on EU funds. The total leverage effect, including private and public funds, is 1:7.
3. The new strategy for the European Research Area (ERA) recommends member countries allocate a target of 5% R&D expenditure to international funding programmes[1].
4. The final allocation of funds from Horizon Europe to the Innovative SMEs Partnership should be proportionate to the budgetary situation of the Framework Programme.
5. Eureka considers an allocation of 300 M€ to the Innovative SMEs Partnership to be an optimal balance between diversity of European interests and sharing the burden of budget cuts, while ensuring the viability of a funding programme with a proven track record for creating jobs and growth.

A Eurostars project partnership has blossomed into an innovative startup, which aims to make the pre-clinical testing of drugs for immune response risks affordable and straightforward. This could help open up the pharmaceutical market to smaller European pharma firms, and ensure that medicines that reach the market do not have unexpected side effects.